Hoth Therapeutics (HOTH) Q2 2024 Earnings

14MayConfirmed
Q4 2022
Q2 2023
Q3 2023
Q2 2024
-1.16
-0.77
-0.39
0

Details

Expected EPS
-0.445
Actual EPS
-0.46
Surprise EPS
-0.02
Surprise Percent
+3.37%

Description

Hoth Therapeutics (HOTH) has reported earnings of -0.46 per share for Q2 2024.

0 Comments

Share your thoughts